by John Conrad | Mar 16, 2020 | COVID, Member News
BIO Business Solutions partner, Scientist.com, has launched a Covid-19 clinical trials tracker and has made it available to everyone at no cost. Scientist.com is an online marketplace for outsourced scientific services and products, offering researchers access to a...
by John Conrad | Mar 15, 2020 | COVID, Member News
Chairman and CEO Albert Bourla Calls on Biopharma Industry to Collaborate on Combatting the Global Pandemic Pfizer today issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat...
by John Conrad | Mar 12, 2020 | COVID, Member News
Advaite, an innovative biotech company focused on developing novel diagnostics, announced today that it will begin supplying the global market with its COVID-19 rapid response diagnostic testing kits, ADVAITE RAPCOV, to help efforts to contain the spread of COVID-19...
by John Conrad | Mar 9, 2020 | COVID, Member News
AbbVie (NYSE:ABBV) today confirmed the company’s activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia (lopinavir/ritonavir) to determine its efficacy in the treatment...
by John Conrad | Mar 9, 2020 | Member News
Local developer brings biotechnology company to Lincoln Park medical research facility Sterling Bay, Chicago’s premiere real estate investment and development firm, and its life sciences division, The Labs, today announced that Exicure, Inc., a pioneer in gene...
by John Conrad | Feb 18, 2020 | Member News
Study to support U.S. FDA approval of the Cordella™ Pulmonary Artery Pressure Sensor System for the treatment of patients with chronic heart failure Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart...
